Clinical Trial Update: Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial investigating amantadine combined with transcranial magnetic stimulation for fatigue in multiple sclerosis; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue
• Multiple Sclerosis

Drugs mentioned

• amantadine (amantadine)

Snippet

Sponsor: Hospital San Carlos, Madrid | Conditions: Multiple Sclerosis, Fatigue | Phase 3 | Status: UNKNOWN